We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Colgate (CL) Gains From Growth Strategies, Cost Woes Persist
Read MoreHide Full Article
Colgate-Palmolive Company (CL - Free Report) is progressing well with product innovation and in-store implementation, which have been key aspects of its growth strategies. The company’s expansion in new markets and investments in brands also bode well. It is set to expand its already strong oral care portfolio with the planned buyout of Hello Products LLC. Meanwhile, the company’s better pricing, strategic marketing, investments in e-commerce capabilities and innovative product launches are aiding its performance.
In the past three months, shares of this Zacks Rank #3 (Hold) company have increased 13.2%, outperforming the industry’s growth of 4.5%.
Factors Narrating Colgate’s Growth Story
Colgate’s innovation strategy is focused on growing adjacent categories and product segments. Further, it is focused on the premiumization of its Oral Care portfolio through major innovations. The company is set to expand its oral care portfolio with the recent announcement of the agreement to buy Hello Products LLC, a leading oral care brand in the United States that produces eco-friendly and organic products. The brand’s products, which have a distinct position in the market, are extremely popular with young consumers and across the broader segment. Further, the brand fully complements the company’s Tom’s of Maine and Colgate brands.
Moreover, the company’s innovation efforts are highlighted by the re-launch of Colgate Total and Hill’s Science Diet as well as the continued expansion of the Naturals and Therapeutics divisions. This, along with accelerated investments in brands and higher pricing, is likely to aid the top line in 2020. Presently, the Naturals range is a key area of focus for the company in personal and home care categories.
The company is also aggressively expanding into faster growth channels while extending the geographic footprint of its brands. In 2019, Colgate expanded its portfolio by introducing pharmacy brands like elmex and meridol to newer markets. Moreover, it remains impressed with the performance of professional skincare businesses — Elta MD and PCA Skin — in spas and dermatologists.
Further, the company expanded its premium skincare portfolio with the buyout of Filorga skincare business. It is also keen on expanding the availability of its products through the e-commerce channel. Moreover, the company is likely to launch the Hill’s to home, which will enable pet parents to purchase prescription diet products directly from their veterinarian, with home delivery option. All these actions are likely to drive top-line growth in 2020.
For 2020, management expects top-line gains, backed by accelerated investment in brands, higher pricing and strong innovation. The company expects top-line growth of 4-6% and organic sales growth of 3-5% for 2020, based on current spot rates. On a GAAP basis, earnings per share for 2020 are likely to increase in a mid to high-single digit. Meanwhile, the company expects adjusted earnings per share to rise in a low to mid-single digit.
Possible Deterrents
Colgate is grappling with higher SG&A expenses for a while now. In the fourth quarter of 2019, the company’s adjusted operating margin contracted mainly due to rise in SG&A expenses on higher advertising investment. Going forward, management anticipates higher advertising spending in 2020 (both on a GAAP and adjusted basis), which may continue hurting its operating income and profitability.
Also, the company is witnessing adverse currency fluctuations for a while now. Adverse currency rates had a 1.5% negative impact on net sales in fourth-quarter 2019. Unfavorable currency also impacted sales across all geographic regions except North America and Africa/Eurasia. Also, raw material costs, which included foreign exchange transaction costs, marred gross margin.
The Procter & Gamble Company (PG - Free Report) has a long-term earnings growth rate of 7.6% and carries a Zacks Rank #2 (Buy).
e.l.f. Beauty, Inc. (ELF - Free Report) delivered positive earnings surprise of 62.5%, on average, in the trailing four quarters. Currently, it carries a Zacks Rank #2.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain. See 5 Stocks Set to Double>>
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Colgate (CL) Gains From Growth Strategies, Cost Woes Persist
Colgate-Palmolive Company (CL - Free Report) is progressing well with product innovation and in-store implementation, which have been key aspects of its growth strategies. The company’s expansion in new markets and investments in brands also bode well. It is set to expand its already strong oral care portfolio with the planned buyout of Hello Products LLC. Meanwhile, the company’s better pricing, strategic marketing, investments in e-commerce capabilities and innovative product launches are aiding its performance.
.jpg)
In the past three months, shares of this Zacks Rank #3 (Hold) company have increased 13.2%, outperforming the industry’s growth of 4.5%.
Factors Narrating Colgate’s Growth Story
Colgate’s innovation strategy is focused on growing adjacent categories and product segments. Further, it is focused on the premiumization of its Oral Care portfolio through major innovations. The company is set to expand its oral care portfolio with the recent announcement of the agreement to buy Hello Products LLC, a leading oral care brand in the United States that produces eco-friendly and organic products. The brand’s products, which have a distinct position in the market, are extremely popular with young consumers and across the broader segment. Further, the brand fully complements the company’s Tom’s of Maine and Colgate brands.
Moreover, the company’s innovation efforts are highlighted by the re-launch of Colgate Total and Hill’s Science Diet as well as the continued expansion of the Naturals and Therapeutics divisions. This, along with accelerated investments in brands and higher pricing, is likely to aid the top line in 2020. Presently, the Naturals range is a key area of focus for the company in personal and home care categories.
The company is also aggressively expanding into faster growth channels while extending the geographic footprint of its brands. In 2019, Colgate expanded its portfolio by introducing pharmacy brands like elmex and meridol to newer markets. Moreover, it remains impressed with the performance of professional skincare businesses — Elta MD and PCA Skin — in spas and dermatologists.
Further, the company expanded its premium skincare portfolio with the buyout of Filorga skincare business. It is also keen on expanding the availability of its products through the e-commerce channel. Moreover, the company is likely to launch the Hill’s to home, which will enable pet parents to purchase prescription diet products directly from their veterinarian, with home delivery option. All these actions are likely to drive top-line growth in 2020.
For 2020, management expects top-line gains, backed by accelerated investment in brands, higher pricing and strong innovation. The company expects top-line growth of 4-6% and organic sales growth of 3-5% for 2020, based on current spot rates. On a GAAP basis, earnings per share for 2020 are likely to increase in a mid to high-single digit. Meanwhile, the company expects adjusted earnings per share to rise in a low to mid-single digit.
Possible Deterrents
Colgate is grappling with higher SG&A expenses for a while now. In the fourth quarter of 2019, the company’s adjusted operating margin contracted mainly due to rise in SG&A expenses on higher advertising investment. Going forward, management anticipates higher advertising spending in 2020 (both on a GAAP and adjusted basis), which may continue hurting its operating income and profitability.
Also, the company is witnessing adverse currency fluctuations for a while now. Adverse currency rates had a 1.5% negative impact on net sales in fourth-quarter 2019. Unfavorable currency also impacted sales across all geographic regions except North America and Africa/Eurasia. Also, raw material costs, which included foreign exchange transaction costs, marred gross margin.
3 Stocks to Consider
DICK'S Sporting Goods, Inc. (DKS - Free Report) delivered positive earnings surprise of 11.5%, on average, in the trailing four quarters. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Procter & Gamble Company (PG - Free Report) has a long-term earnings growth rate of 7.6% and carries a Zacks Rank #2 (Buy).
e.l.f. Beauty, Inc. (ELF - Free Report) delivered positive earnings surprise of 62.5%, on average, in the trailing four quarters. Currently, it carries a Zacks Rank #2.
Free: Zacks’ Single Best Stock Set to Double
Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.
See 5 Stocks Set to Double>>